All Videos

In the final installment of this video series, Paige Velasquez Budde, CEO of Zilker Media, provides some useful tips for jump starting your brand as a physician.

In part two of this video series, Paige Velasquez Budde, CEO of Zilker Media, reveals the benefits of shaping your brand awareness.

In this video interview, Paige Velasquez Budde, CEO of Zilker Media, explains the importance of building and shaping your brand as a physician.

Dr. Jack Levy, chief resident in the Department of Dermatology at Emory University, discusses his recent presentation at the 2020 ASDS meeting about using high frequency ultrasound to distinguish scar tissue from neoplasm.

Dr. Mary Lynn Moran, the first female president of the AAFPRS, offers advice for helping women in plastic surgery achieve leadership positions within the specialty.

Dr. Katarina Kesty, St. Petersburg Skin and Laser, St. Petersburg, Fla., discusses her presentation at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting about her research using abobotulinumtoxinA injections to combat oil on the forehead.

In the final part of our interview with Candrice Heath, M.D., she discusses some of the treatment challenges associated with treating pediatric patients with skin of color and how to overcome these obstacles.

In part two of our interview with Candrice Heath, M.D., she explains the most commonly encountered skin conditions when treating young skin of color patients.

Candrice Heath, M.D., shares her tips and tricks for treating young skin of color patients from her presentation at the 2020 Skin of Color Update.

Vinod E. Nambudiri, M.D., MBA, breaks down tools the specialty can use to expand telehealth services to underserved communities.

Described as a paper that sits at the intersection of data and action, plastic and reconstructive surgeon Paris Butler, MD, says this research provides a roadmap to diversifying surgical leadership.

What are some of the challenges of expanding teledermatology to underserved communities? Sepideh Ashrafzadeh answers this question in part four of our video interview.

In part three of our conversation, Sepideh Ashrafzadeh details sustainable steps the specialty can take to expand access to care to new and underserved communities during the current pandemic – and in the future.

In part two of our conversation on expanding care to underserved populations through telehealth, expert Vinod E. Nambudiri, M.D., MBA, dives into the disparities that most affect the specialty of dermatology.

Could the eased telehealth restrictions implemented in response to the COVID-19 pandemic allow for greater access to dermatologic care? We sat down with experts to explore how telehealth could be used to expand quality care to vulnerable and underserved populations across the United States.

Vitiligo can be psychologically devastating for patients. Expert Seemal R. Desai, M.D., FAAD, shares how recent advances in vitiligo treatment offer hope to patients impacted by the disease.

Subtypes such as confetti vitiligo and trichrome vitiligo can be signs of unstable active disease, says expert Seemal R. Desai, M.D., FAAD.

Expert Seemal R. Desai, M.D., FAAD, highlights new therapeutics that may impact the future of vitiligo management, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

Antioxidants can be a valuable part of your vitiligo therapeutic armamentarium, says expert Seemal R. Desai, M.D., FAAD.

Expert Seemal R. Desai, M.D., FAAD, offers practical tips for stabilizing patients who present with active, spreading vitiligo, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

Is your patient’s vitiligo stable, unstable or recalcitrant? Expert Seemal R. Desai, M.D., FAAD, discusses how he classifies disease activity in his practice.

Expert Seemal R. Desai, M.D., FAAD, stresses the importance of defining treatment goals when meeting with vitiligo patients, a topic he covered during his presentation at the AAD Virtual Meeting Experience (VMX) in June.

Expert Christine Ko, M.D., FAAD, discusses case reports exploring the variability of skin manifestation in patients with or suspected of COVID-19 infection.

Most skin manifestations associated with COVID-19 resolve as the disease progresses, says expert Christine Ko, M.D., FAAD. But there is one type of lesion that providers and patients will not want to ignore, she warns.

Learn about the histopathology of skin findings associated with potential COVID-19 infection from expert Christine Ko, M.D., FAAD.

Dr. Randolph Waldman shares details about his overall high patient retention rate and continuing demand for procedures during the ongoing COVID-19 pandemic.

Will the current practice of using telemedicine for acne care have an impact on the future of dermatology? We spoke with Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, on the topic.

Virtual visits may allow providers to focus more on patient education, says Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama.

Dr. Waldman offers an update on processes and protocols for the private practice during the COVID-19 pandemic.

Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, discusses how she approaches treating acne via virtual visits after incorporating telemedicine into her practice due to the COVID-19 pandemic.